S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Calvin L. Colvin,Jordan B. King,Jordan B. King,Suzanne Oparil,Jackson T. Wright,Gbenga Ogedegbe,April F. Mohanty,April F. Mohanty,Shakia T Hardy,Lei Huang,Rachel Hess,Paul Muntner,Adam P. Bress +12 more
TL;DR: There was no statistically significant change in the proportion of Black beneficiaries initiating antihypertensive monotherapy with an angiotensin-converting enzyme inhibitor or angiotENSin receptor blocker following publication of the panel members’ report.
Journal ArticleDOI
Hyperoxia-induced converting enzyme insufficiency in conscious rat: cardiovascular effects.
TL;DR: The data suggest that O2 induced impairment in activity of angiotensin-converting enzyme at the endothelial membrane level has functionally significant effects on cardiovascular homeostasis, probably via reduced generation of endogenous AII.
Journal ArticleDOI
Updated Guidelines for Management of High Blood Pressure in Japan
TL;DR: The JSH 2014 Report acknowledges the importance of primary care clinicians, as well as teams that include nurses, dieticians and pharmacists, in caring for hypertensive patients in Japan, and directs its recommendations toward all of these groups.
Journal ArticleDOI
Effect of hypoxia on the conversion of angiotensin I to II in cultured porcine pulmonary endothelial cells
TL;DR: The results of this study are consistent with earlier observations by the authors which suggest that hypoxia-induced depression of angiotensin I conversion in vivo is due to hemodynamic phenomena.
Journal Article
Hypertension and oral contraceptives.
TL;DR: Patients who develop hypertension on oral contraceptives should stop taking the pills immediately, and should be considered to have estrogen-induced hypertension, as most women who become hypertensive on oral pills go on to have normotensive pregnancies.